Friess Associates LLC Illumina, Inc. Transaction History

Friess Associates LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$209.2 - $335.53 $7.29 Million - $11.7 Million	-34,842 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$288.29 - $335.49 $9.17 Million - $10.7 Million	-31,805 Reduced 47.72%	34,842 $11.6 Million
Q3 2019 Nov 14, 2019	BUY	$266.84 - $378.23 $17.8 Million - $25.2 Million	66,647 New	66,647 $20.3 Million
Q1 2019 May 15, 2019	SELL	$272.57 - $321.18 $8.41 Million - $9.91 Million	-30,850 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$272.46 - $366.54 $8.41 Million - $11.3 Million	30,850 New	30,850 $9.25 Million
Q1 2018 May 15, 2018	SELL	$209.54 - $253.91 $22.4 Million - $27.1 Million	-106,825 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$202.23 - $230.03 $48,535 - $55,207	-240 Reduced 0.22%	106,825 $23.3 Million
Q3 2017 Nov 14, 2017	BUY	$172.3 - $213.93 $18.4 Million - $22.9 Million	107,065	107,065 $21.3 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.